Top Markets
#1 0G 0G +29.20%
#2 SAFEcoin SAFEcoin +21.02%
#3 Cysic Cysic +20.97%
#4 Zora Zora +19.25%
#5 Full Moon Full Moon +18.99%
#6 Axelar Axelar +18.01%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.73%
#8 StonkBroker StonkBroker +16.18%
#9 VVS Finance VVS Finance +15.88%
#10 AI XOVIA AI XOVIA +15.87%
Coin of the day
0G 0G
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rang in aandelen #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Aandeelprijs
$4.51
Marktkapitalisatie
$540.82M
Verandering (1 dag)
-2.42%
Verandering (1 jaar)
-43.50%
Land
CN
Handel Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Categorie

Healthcare
P/S-ratio voor Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Nanjing Hicin Pharmaceutical Co., Ltd. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Nanjing Hicin Pharmaceutical Co., Ltd. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 -
IN